» Articles » PMID: 25485708

A Retrospective Study: Factors Associated with the Risk of Abdominal Aortic Aneurysm Rupture

Overview
Date 2014 Dec 9
PMID 25485708
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Literature regarding pharmacological manipulation of aneurysm development and progression is abundant; however studies looking at preventing rupture are sparse. Moreover, best medical therapy is ill-instituted, and continued in this high-risk cohort. This paper aims to identify factors which affect the risk of AAA-rupture.

Materials & Methods: A retrospective review of patients undergoing non-screen detected AAA-repair at a single tertiary-referral centre was performed. Age, cardiovascular history, medication use and the nature of surgical repair (elective or emergency) were converted to binary characteristics and a binomial logistic regression performed.

Results: We included 315 admissions for ruptured AAA, and 668 referrals for elective repair of large aneurysms (n=983). Multifactorial analysis showed that the cohort which was prescribed statins experienced fewer ruptured AAA ([OR] 0.50, [95% CI] 0.32-0.77). Factors associated with increased risk of rupture include female gender (2.49, 1.63-3.80), history of hypertension (3.5, 1.6-3.8) or renal failure (8.08, 4.15-15.4), age over 80 (2.77, 1.79-4.27) and current smoking (1.80, 1.09-2.96).

Discussion And Conclusions: This is the largest study, interrogating individual patient data, to suggest an association between statins and prevention of large AAA-rupture. As patients with AAA are at high risk of cardiovascular events, and statins may decrease the risk of the devastating consequence of the condition, healthcare teams should maintain pharmaco-vigilance in instituting and continuing best medical therapy, including a statin.

Citing Articles

Pre-operative predictors of mortality in ruptured abdominal aortic aneurysms: is the Harborview Medical Center mortality risk score enough?.

Yucel S, Caliskan F Ulus Travma Acil Cerrahi Derg. 2023; 29(11):1261-1268.

PMID: 37889027 PMC: 10771243. DOI: 10.14744/tjtes.2023.82770.


Double-edged sword of diabetes mellitus for abdominal aortic aneurysm.

Huang Z, Su H, Zhang T, Li Y Front Endocrinol (Lausanne). 2023; 13:1095608.

PMID: 36589814 PMC: 9800781. DOI: 10.3389/fendo.2022.1095608.


Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis.

Su Z, Guo J, Gu Y Clin Appl Thromb Hemost. 2022; 28:10760296221120423.

PMID: 36083182 PMC: 9465599. DOI: 10.1177/10760296221120423.


Derivation and Validation of a 10-Year Risk Score for Symptomatic Abdominal Aortic Aneurysm: Cohort Study of Nearly 500 000 Individuals.

Welsh P, Welsh C, Jhund P, Woodward M, Brown R, Lewsey J Circulation. 2021; 144(8):604-614.

PMID: 34167317 PMC: 8378547. DOI: 10.1161/CIRCULATIONAHA.120.053022.


Comprehensive Cardiac Rehabilitation as a Therapeutic Strategy for Abdominal Aortic Aneurysm.

Nakayama A, Morita H, Komuro I Circ Rep. 2021; 1(11):474-480.

PMID: 33693088 PMC: 7897575. DOI: 10.1253/circrep.CR-19-0095.